In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Multi-parameter Chlamydia trachomatis and Neisseria gonorrhea (CT/NG) Nucleic Acid Amplification Tests (NAAT) are used to simultaneously detect both Chlamydia trachomatis and Neisseria gonorrhea from the same sample, providing convenience in screening and diagnosis. GlobalData uses proprietary data and analytics to provide a comprehensive report on the multi-parameter ct/ng naats market in Israel. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the multi-parameter ct/ng naats market in Israel was Abbott Laboratories followed by Becton Dickinson and Co, Danaher, F. Hoffmann-La Roche and Hologic.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Multi-parameter Chlamydia trachomatis and Neisseria gonorrhea (CT/NG) Nucleic Acid Amplification combination test uses PCR or Ligase chain reaction methods to amplify nucleic acid sequences of C. trachomatis and N. gonorrhea, by targeting specific nucleic acid sequences. The process involves a polymerase chain reaction or ligase chain reaction with specific primers, nucleotide triphosphates, and taq polymerase leading to the production of detectable amounts of DNA or RNA. DNA or RNA is used as a template for transcription and reverse transcription reactions in series also known as transcription mediated amplification or nucleic acid sequence-based amplification.

The multi-parameter ct/ng naats market in Israel can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size multi-parameter ct/ng naats in Israel, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.